⚠ Rivals Learn to Compete on TermsLow threat

Berkshire Hathaway (BRK.B) — threat to the moat

Permanent-capital imitators now borrow the Berkshire pitch word for word.

Berkshire's alignment and permanence were once nearly unique, but rivals have studied the model and increasingly imitate its most attractive features. A growing number of long-hold private-equity funds, family offices, and permanent-capital vehicles now court sellers with promises of patient ownership and light-touch stewardship, explicitly borrowing Berkshire's pitch. As the market for good businesses grows more crowded with buyers offering similar assurances, Berkshire's differentiation narrows and it must compete harder for deals it once won by default.

Cash paid for businesses by year ($B)$3.3B2018$1.7B2019$2.5B2020$0.5B2021$10.6B2022$8.6B2023$0.4B2024$1.1B2025Acquisitions net of cash acquired; Forms 10-K FY2020, FY2022, FY2025
Only two years in eight saw a deal of any size.

The danger is gradual erosion rather than sudden loss. Berkshire's promise is still the most credible — backed by a genuine half-century record no imitator can yet match — but 'most credible' is a smaller edge than 'only credible,' and it may mean paying somewhat more, or winning somewhat fewer, of the wonderful family businesses that were once its special preserve. A commoditized promise of patient ownership is worth less than a rare one.

This is a slow competitive pressure rather than a threat to the moat. Berkshire's scale, its ability to write enormous checks quickly, and its unmatched track record keep it near the front of any seller's mind, and imitators' promises remain less proven. But an owner should recognize that the seller-of-choice advantage, like any good idea in business, invites imitation, and that the pool of buyers credibly offering what only Berkshire once could is slowly growing — even as $365.5 billion of cash and Treasury bills at the end of June 2026 lets it write checks no one else can.12

References
  1. ReportedBut an owner should recognize that the seller-of-choice advantage, like any good idea in business, invites imitation, and that the pool of buyers credibly offering what only Berkshire once could is slowly growing — even as $365.5 billion of cash and Treasury bills at the end of June 2026 lets it write checks no one else can.
    Berkshire Hathaway Form 10-Q, quarter ended 30 June 2026 - after-tax earnings (underwriting $1,731M vs $1,992M, insurance investment income $3,059M vs $3,367M, BNSF $1,558M vs $1,466M, BHE $891M vs $702M, manufacturing, service and retailing $4,470M vs $3,601M, investment gains $12,684M, net earnings $25,667M); GEICO pre-tax underwriting $994M vs $1,821M, combined ratio 91.2% vs 83.5%; Reinsurance $913M vs $650M; float $177.5B; insurance and other cash and Treasury Bills net $359.2B; consolidated cash $35,096M + $324,905M + $5,513M; equity securities $323.8B; H1 purchases of equities $39.4B and sales $27.8B; acquisitions of businesses net of cash $9.7B; $4.8B of treasury stock acquired in H1, most in Q2; OxyChem about $9.4B on 2 January; Taylor Morrison agreed 31 May at $72.50 a share, about $6.8B, closed 24 July; notes payable of insurance and other $43.3B; shareholders' equity $747.9B; BNSF revenue $6,601M vs $5,769M, fuel $1,173M vs $698M; BHE revenue $6,735M vs $6,418M; investment income down 9.1% on lower interest rates — Q2 2026 · publ. August 2026 · source ↗
  2. Moat Explorer calcBut an owner should recognize that the seller-of-choice advantage, like any good idea in business, invites imitation, and that the pool of buyers credibly offering what only Berkshire once could is slowly growing — even as $365.5 billion of cash and Treasury bills at the end of June 2026 lets it write checks no one else can.
    Moat Explorer calculation from Berkshire's Forms 10-K FY2016-FY2025 and 10-Qs for Q1 and Q2 2026: operating earnings = net earnings less after-tax investment gains and the 2025 impairments (FY2023 $37,350M, FY2024 $47,437M, FY2025 $44,486M; Q2 2026 $12,983M vs $11,160M; H1 2026 $24,329M vs $20,801M); consolidated cash and Treasury Bills $397.4B (31 March 2026) and $365.5B (30 June 2026); underwriting as a share of float; OxyChem at 2.6% of the cash pile; five-line after-tax earnings sums — 2016 to Q2 2026 · publ. 2026-09-23 · source ↗
Sources
Generated September 23, 2026